Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Cogent Biosciences, Inc. Banner

Cogent Biosciences, Inc.

COGT Stock Analysis

Page title

Section title

Breakdown
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-6.592m-18.124m-25.492m-34.532m-31.833m-74.808m-72.273m-140.241m-192.410m
Depreciation & Amortization
179.000K830.000K1.171M1.321M1.293M720.000K147.000K5.878M3.588M
Change in Working Capital
23.881M-2.323m-2.879m-2.153m-14.084m-5.316m2.020M751.000K11.442M
Operating Cash Flow
17.716M-18.640m-25.835m-32.489m-41.514m-35.850m-58.763m-118.638m-153.624m
Capital Expenditure
-1.994m-3.307m-912.000k-549.000k-33.000k0.000-1.719m-6.863m-2.796m
Free Cash Flow
15.722M-21.947m-26.747m-33.038m-41.547m-35.850m-60.482m-125.501m-156.420m
Debt Repayment
0.0000.0000.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
70.752M0.00060.000K71.793M108.000K132.729M38.006M163.558M163.536M
Common Stock Repurchased
0.0000.0000.0000.0000.0000.0000.0000.0000.000
Net Change in Cash
85.219M-49.109m-13.051m27.326M-18.247m204.766M-22.506m-79.798m-87.912m